Stockscreener 앱 받기
1.54
1.28%
-0.02
Actinium Pharmaceuticals Inc 주식(ATNM)의 최신 뉴스
Has Actinium Pharmaceuticals Inc. formed a bullish divergenceNeural Model for Stock Price Movement - Newser
What’s the recovery path for long term holders of Actinium Pharmaceuticals Inc.Free AI Driven Buy Alert Trade Blueprint - Newser
Actinium Pharmaceuticals Inc. stock daily chart insightsFree Earnings Play Trade Plan With Alerts - Newser
Visual analytics tools that track Actinium Pharmaceuticals Inc. performanceAsset Safety Selection Using Quantitative Analysis - Newser
Analyzing drawdowns of Actinium Pharmaceuticals Inc. with statistical toolsBuy and Exit Strategy Based on Momentum - Newser
Actinium Pharmaceuticals Inc.’s volatility index tracking explainedWeekly Trend Screener with Momentum Picks - Newser
Analyzing Actinium Pharmaceuticals Inc. with risk reward ratio chartsDividend Strategy Summary With 10-Year Outlook - Newser
Published on: 2025-08-09 00:23:20 - Newser
Can Actinium Pharmaceuticals Inc. hit a new high this monthConsistent Profit Signals with AI Models - Newser
Visualizing Actinium Pharmaceuticals Inc. stock with heatmapsTrade Ideas Based on Fundamental Metrics - Newser
Actinium: Q2 Earnings Snapshot - San Francisco Chronicle
Is Actinium Pharmaceuticals Inc. a Top Dividend Stock to Watch in 2025Immediate Entry Point Prediction Strategy - Newser
Financial Contrast: Gemini Therapeutics (NASDAQ:GMTX) & Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
What institutional flow reveals about Actinium Pharmaceuticals Inc.Investment Position Summary with Timeframe Forecast - Newser
Can machine learning forecast Actinium Pharmaceuticals Inc. recoveryShort Term Profit Strategy with Entry Cues - Newser
What moving averages say about Actinium Pharmaceuticals Inc.AI Intraday Market Movement Prediction Tool - Newser
Is it time to cut losses on Actinium Pharmaceuticals Inc.Volatility Analysis and Entry Risk Mapping - Newser
How strong is Actinium Pharmaceuticals Inc. company’s balance sheetFree Buy/Sell Signal Notifications - Jammu Links News
What are the latest earnings results for Actinium Pharmaceuticals Inc.Consistent triple-digit returns - Jammu Links News
What analysts say about Actinium Pharmaceuticals Inc. stockSuperior returns - Jammu Links News
What is the dividend policy of Actinium Pharmaceuticals Inc. stockHigh-performance stocks for savvy investors - Jammu Links News
Is it the right time to buy Actinium Pharmaceuticals Inc. stockAccelerated capital growth - Jammu Links News
What institutional investors are buying Actinium Pharmaceuticals Inc. stockAchieve breakthrough gains with expert advice - Jammu Links News
How does Actinium Pharmaceuticals Inc. compare to its industry peersGet daily expert analysis on top stocks - Jammu Links News
When is Actinium Pharmaceuticals Inc. stock expected to show significant growthAchieve consistent double-digit returns - Jammu Links News
What is Actinium Pharmaceuticals Inc. company’s growth strategyExceptional growth trajectory - jammulinksnews.com
What are analysts’ price targets for Actinium Pharmaceuticals Inc. in the next 12 monthsInvest confidently with market-leading analysis - Jammu Links News
Is Actinium Pharmaceuticals Inc. a growth stock or a value stockUnprecedented market success - Jammu Links News
What makes Actinium Pharmaceuticals Inc. stock price move sharplyDaily Technical Forecast for Quick Gains - Newser
Key External Factors That Drive Actinium Pharmaceuticals Inc. Stock Price MovementsReal Time Growth Signal with Smart Setup - Newser
Actinium Pharmaceuticals shares rise 5.73% intraday after presenting positive data for ATNM-400 in prostate cancer treatment. - AInvest
Actinium Presents Data Supporting Paradigm Changing Potential of ATNM-400 in Prostate Cancer Demonstrating Its Superior Efficacy and Improved Survival in Treatment Resistant Tumor Models versus Pluvicto and ARPI Therapy, and Also Enhanced Efficac - PR Newswire
Will Actinium Pharmaceuticals Inc. Stock Benefit from AI and Green Energy TrendsFree Risk Managed Intraday Trade Alerts - Newser
Actinium Pharmaceuticals’ ATNM-400 Shows Promise in Prostate Cancer Treatment, Earning Buy Rating - TipRanks
Actinium Pharmaceuticals Inc. recovery potential after sell offWatchlist Generator for Smart Money Signals - Newser
Published on: 2025-07-31 05:11:29 - metal.it
What’s next for Actinium Pharmaceuticals Inc. stock priceTrade Scanner With Buy Zone Alerts Flagged - metal.it
Why Actinium Pharmaceuticals Inc. stock attracts strong analyst attentionEarly Entry Tips With Low Risk Zone Shared - metal.it
How Actinium Pharmaceuticals Inc. stock performs during market volatilityShort Term Alpha Signals Insight - beatles.ru
How to interpret RSI for Actinium Pharmaceuticals Inc. stockChart Based Entry Tool for ROI Traders - Newser
Actinium Pharmaceuticals Inc.’s Price Action Aligns with Quant SignalsTriple Digit Return Stock Predictions Released - beatles.ru
Can Actinium Pharmaceuticals Inc. Rally Enough to Break EvenTriple Return Setup With Risk Control Explained - metal.it
Published on: 2025-07-29 14:09:30 - metal.it
Is Actinium Pharmaceuticals Inc. showing signs of accumulationMarket Downturn Defense Strategy Analysis - Newser
Is Actinium Pharmaceuticals Inc. stock a growth or value playFree Smart Trend Trading with Weekly Signals - Newser
Does Actinium Pharmaceuticals Inc. fit your quant trading modelDaily Market Momentum and Pressure Analysis - Newser
0.24%
3.39%
자본화:
|
볼륨(24시간):